Just to show again that s@#t can happen, I'm not saying that the same has occurred in BTX1503 phase2, but just to show that interpreting the trial 'anomaly' remains -at best- challenging:
https://www.fiercebiotech.com/biotech/placebo-drug-mixup-adds-subplot-to-helixmith-phase-3-failure
" An analysis of samples taken from people in the placebo arm found DNA used in VM202, suggesting investigators may have administered the experimental therapy to people in the control group."
http://www.koreabiomed.com/news/articleView.html?idxno=6501
"The company’s pharmacokinetic (PK) data analysis found high levels of VM202 in 36 patients in the placebo group, and low levels of VM202 in 32 patients in the drug-treated group."
Wishing all long term holders a great and safe Holiday Season.
Just to show again that s@#t can happen, I'm not saying that the...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $690.6M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 38.0¢ | $120.9K | 318.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 482100 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 148954 | 8 |
View Market Depth
| Last trade - 11.02am 10/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |